Lasa Supergenerics launches new product Oxyclozanide

09 Jun 2021 Evaluate

Lasa Supergenerics has launched new product Oxyclozanide. Oxyclozanide is an anthelmintic. It is used in the treatment and control of fascioliasis a topical worm infection in ruminants mainly domestic animals such as cattle (especially buffalos in farm), sheep, and goats. For this, the company is setting up capacity in a brown field expansion at its Chiplun unit. The total capacity would be 250 MT and the company is committed to funding the required Capex through internal accruals. The production would start from August 2021.

The product is in huge demand and the management is confident of having a strong order book from the time production commences. The company already has export approvals for several regions. Oxyclozanide would also be exported to these regions.

Lasa Supergenerics is pioneer and amongst the leading players in the manufacturing of APIs in India through its catalyst chemistry expertise and fully backward integrated unit.

Lasa Supergenerics Share Price

9.90 -0.10 (-1.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×